Patents Assigned to SENGENICS SDN BHD
  • Publication number: 20220260571
    Abstract: A method for diagnosing Non-Small Cell Lung Cancer (NSCLC) from a sample extracted from a subject by testing the sample for the presence of biomarkers, the biomarkers being autoantibodies against XAGE1D, LRRFIP2 and GAGE2C. Also claimed are a method of manufacturing a kit, and compositions comprising a panel of said antigens or exosomal autoantibodies.
    Type: Application
    Filed: December 12, 2019
    Publication date: August 18, 2022
    Applicants: SENGENICS SDN BHD, NATIONAL UNIVERSITY OF SINGAPORE
    Inventors: Jonathan Michael BLACKBURN, Arif ANWAR, Boon Cher GOH, Lingzhi WANG, Sok Hwee Esther CHEOW, Ross Andrew SOO, Win Lwin THUYA